Literature DB >> 16209543

Proteomic profiling of Escherichia coli proteins under high cell density fed-batch cultivation with overexpression of phosphogluconolactonase.

Yonghui Wang1, Shiaw-Lin Wu, William S Hancock, Robin Trala, Michelle Kessler, Alexander H Taylor, Pramatesh S Patel, Juan C Aon.   

Abstract

In this study, we used proteomics to better understand the growth on glucose of Escherichia coli in high cell density, fed-batch cultures and the response to overexpression of plasmid-encoded 6-phosphogluconolactonase (PGL). Using liquid chromatography coupled to electrospray mass spectrometry, at least 300 proteins were identified in the cytosolic fraction of the six time points used to monitor the fermentation. The relative abundance changes of selected proteins were obtained by comparing the peak area of the corresponding peptides at a particular m/z (mass over charge ratio) value. During the time course of samples collected during the rapid growth achieved under batch and fed-batch conditions, both the control and recombinant E. coli strains showed up-regulation of proteins participating in the tricarboxylic acid (TCA) cycle, particularly acetyl-CoA synthetase (AcCoAS), malate dehydrogenase (MDH), and succinyl-CoA synthetase (SuccCoAS). In the recombinant strain culture, fumarase was up-regulated until 35 h after inoculation but was not in the control strain culture. In addition, the proteomic measurement detected up-regulation of three well-characterized binding transport proteins in both control and recombinant strains. The up-regulation of TCA cycle enzymes is consistent with the increase in growth rate observed in the cell culture. In addition, up-regulation of these proteins demonstrated the importance of both the pentose-phosphate shunt and TCA cycle to the increased biosynthetic activity required by a high level protein synthesis. This study shows the potential of proteomics using shotgun sequencing (LC/MS of tryptic digests) to measure global changes in protein abundance during a fermentation process and will facilitate the development of robust manufacturing systems.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16209543     DOI: 10.1021/bp050048m

Source DB:  PubMed          Journal:  Biotechnol Prog        ISSN: 1520-6033


  7 in total

1.  Recombinant E. coli expressing Vitreoscilla haemoglobin prefers aerobic metabolism under microaerobic conditions: a proteome-level study.

Authors:  Bini Ramachandran; Kanak Lata Dikshit; Kuppamuthu Dharmalingam
Journal:  J Biosci       Date:  2012-09       Impact factor: 1.826

Review 2.  The Escherichia coli proteome: past, present, and future prospects.

Authors:  Mee-Jung Han; Sang Yup Lee
Journal:  Microbiol Mol Biol Rev       Date:  2006-06       Impact factor: 11.056

3.  Protein solubility and differential proteomic profiling of recombinant Escherichia coli overexpressing double-tagged fusion proteins.

Authors:  Chung-Hsien Cheng; Wen-Chien Lee
Journal:  Microb Cell Fact       Date:  2010-08-28       Impact factor: 5.328

4.  Suppressing posttranslational gluconoylation of heterologous proteins by metabolic engineering of Escherichia coli.

Authors:  Juan C Aon; Richard J Caimi; Alexander H Taylor; Quinn Lu; Femi Oluboyede; Jennifer Dally; Michelle D Kessler; John J Kerrigan; Tia S Lewis; Lisa A Wysocki; Pramatesh S Patel
Journal:  Appl Environ Microbiol       Date:  2007-12-14       Impact factor: 4.792

5.  Metabolic engineering of Escherichia coli for the production of riboflavin.

Authors:  Zhenquan Lin; Zhibo Xu; Yifan Li; Zhiwen Wang; Tao Chen; Xueming Zhao
Journal:  Microb Cell Fact       Date:  2014-07-16       Impact factor: 5.328

6.  Improvement of coenzyme Q10 production: mutagenesis induced by high hydrostatic pressure treatment and optimization of fermentation conditions.

Authors:  Yahong Yuan; Yuting Tian; Tianli Yue
Journal:  J Biomed Biotechnol       Date:  2012-10-02

7.  Metabolic network reconstruction and phenome analysis of the industrial microbe, Escherichia coli BL21(DE3).

Authors:  Hanseol Kim; Sinyeon Kim; Sung Ho Yoon
Journal:  PLoS One       Date:  2018-09-21       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.